A phase II study of patupilone in patients with metastatic hormone refractory prostate cancer (HRPC) who have progressed after docetaxel Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chi, KN
  • Beardsley, EK
  • Venner, PM
  • Eigl, BJ
  • Hotte, Sebastien
  • Ko, Y
  • Saad, F
  • Winquist, E

publication date

  • May 20, 2008